Table I.
Patient characteristics (n=104).
| Characteristics | Patients, no. (%) |
|---|---|
| Gender | |
| Male | 49 (47.0) |
| Female | 55 (53.0) |
| Median age, years (range) | 62 (42–75) |
| ECOG PS | |
| 0 or 1 | 67 (64.0) |
| 2 or 3 | 37 (36.0) |
| Histology | |
| Adenocarcinoma | 101 (97.0) |
| Not otherwise specified | 3 (3.0) |
| EGFR mutation | |
| Exon 19 deletion | 60 (58.0) |
| L858R mutation | 44 (42.0) |
| Disease stage | |
| IIIB | 10 (9.6) |
| IV | 84 (80.8) |
| Recurrence | 10 (9.6) |
| Number of prior regimens | |
| 0 | 65 (62.5) |
| ≥1 | 39 (37.5) |
ECOG PS, Eastern Cooperative Oncology Group performance status; EGFR, epidermal growth factor receptor.